Collegium Pharmaceutical (COLL) PT Lowered to $36 at Piper Sandler
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $22.92 --0%
Rating Summary:
9 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 34
Rating Summary:
9 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 34
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $36.00 (from $37.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Stifel Reiterates Buy Rating on AMD (AMD), Constructive on Durability of EPYC Ramp
- UBS Upgrades Lovisa Holdings Ltd (LOV:AU) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
